Diagnosis of asbestos-related lung diseases
Introduction: The diagnosis of lung disease in asbestos-exposed individuals is a process that not only requires a detailed occupational and tobacco smoking history, but the correlation with physical signs, appropriate imaging, detailed lung function assessment and histology/cytology when required. W...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/20.500.11937/74194 |
| _version_ | 1848763205258575872 |
|---|---|
| author | Harris, E. Musk, A. de Klerk, N. Reid, Alison Franklin, P. Brims, Fraser |
| author_facet | Harris, E. Musk, A. de Klerk, N. Reid, Alison Franklin, P. Brims, Fraser |
| author_sort | Harris, E. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Introduction: The diagnosis of lung disease in asbestos-exposed individuals is a process that not only requires a detailed occupational and tobacco smoking history, but the correlation with physical signs, appropriate imaging, detailed lung function assessment and histology/cytology when required. Worldwide, the total quantity of asbestos mined is static, having decreased dramatically in developed countries but increased in countries where there is no restriction on mining: for example, Russia, China, Brazil, and Kazakhstan. The predominant diagnostic challenge in most cases of possible asbestos-related disease is the significant interval between exposure and development of the disease. Also challenging is the estimation of an individual's risk of disease, not least because asbestos-induced malignancy can be rapidly fatal, and, in the case of lung cancer, early detection can lead to treatment with curative intent. Areas covered: Discussion of quantitative asbestos exposure estimation and risk assessment, selection of the most appropriate imaging modality and frequency of imaging. Expert commentary: Consideration of the future for asbestos-related lung disease includes screening those at highest risk particularly in relation to ongoing mining operations and the management of in-situ asbestos. In the future, screening programs designed with estimation of risk of malignancy, based on quantitative estimates of asbestos exposure, and smoking history are indicated. |
| first_indexed | 2025-11-14T10:59:45Z |
| format | Journal Article |
| id | curtin-20.500.11937-74194 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:59:45Z |
| publishDate | 2019 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-741942019-08-01T07:37:01Z Diagnosis of asbestos-related lung diseases Harris, E. Musk, A. de Klerk, N. Reid, Alison Franklin, P. Brims, Fraser Introduction: The diagnosis of lung disease in asbestos-exposed individuals is a process that not only requires a detailed occupational and tobacco smoking history, but the correlation with physical signs, appropriate imaging, detailed lung function assessment and histology/cytology when required. Worldwide, the total quantity of asbestos mined is static, having decreased dramatically in developed countries but increased in countries where there is no restriction on mining: for example, Russia, China, Brazil, and Kazakhstan. The predominant diagnostic challenge in most cases of possible asbestos-related disease is the significant interval between exposure and development of the disease. Also challenging is the estimation of an individual's risk of disease, not least because asbestos-induced malignancy can be rapidly fatal, and, in the case of lung cancer, early detection can lead to treatment with curative intent. Areas covered: Discussion of quantitative asbestos exposure estimation and risk assessment, selection of the most appropriate imaging modality and frequency of imaging. Expert commentary: Consideration of the future for asbestos-related lung disease includes screening those at highest risk particularly in relation to ongoing mining operations and the management of in-situ asbestos. In the future, screening programs designed with estimation of risk of malignancy, based on quantitative estimates of asbestos exposure, and smoking history are indicated. 2019 Journal Article http://hdl.handle.net/20.500.11937/74194 10.1080/17476348.2019.1568875 restricted |
| spellingShingle | Harris, E. Musk, A. de Klerk, N. Reid, Alison Franklin, P. Brims, Fraser Diagnosis of asbestos-related lung diseases |
| title | Diagnosis of asbestos-related lung diseases |
| title_full | Diagnosis of asbestos-related lung diseases |
| title_fullStr | Diagnosis of asbestos-related lung diseases |
| title_full_unstemmed | Diagnosis of asbestos-related lung diseases |
| title_short | Diagnosis of asbestos-related lung diseases |
| title_sort | diagnosis of asbestos-related lung diseases |
| url | http://hdl.handle.net/20.500.11937/74194 |